loadpatents
Patent applications and USPTO patent grants for KHAN; Shireen.The latest application filed is for "cd47 antibody, preparation method therefor and uses thereof".
Patent | Date |
---|---|
Cd47 Antibody, Preparation Method Therefor And Uses Thereof App 20220017615 - LIU; Lile ;   et al. | 2022-01-20 |
Anti-pd-1/lag3 Bispecific Antibodies App 20210371530 - FAYADAT-DILMAN; Laurence ;   et al. | 2021-12-02 |
Anti-pd-1/lag3 Bispecific Antibodies App 20210363256 - FAYADAT-DILMAN; Laurence ;   et al. | 2021-11-25 |
Anti-PD-1/LAG3 bispecific antibodies Grant 11,072,658 - Fayadat-Dilman , et al. July 27, 2 | 2021-07-27 |
Anti-pd-1 Antibodies App 20210032342 - FAYADAT-DILMAN; Laurence ;   et al. | 2021-02-04 |
Anti-pd-1/lag3 Bispecific Antibodies App 20190233518 - Fayadat-Dilman; Laurence ;   et al. | 2019-08-01 |
Device and method for measuring LDL-associated cholesterol Grant 7,824,879 - Khan , et al. November 2, 2 | 2010-11-02 |
Device and method for measuring LDL-associated cholesterol App 20080166745 - Khan; Shireen ;   et al. | 2008-07-10 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.